BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1776283)

  • 1. [Tumor markers in diagnosis of breast cancer].
    Bartel U
    Z Arztl Fortbild (Jena); 1991 Oct; 85(20):1015-21. PubMed ID: 1776283
    [No Abstract]   [Full Text] [Related]  

  • 2. [Initial experiences with CA-15-3 determination in the serum of patients with breast cancer].
    Bartel U; Johannsen B; Reiss H; Elling D
    Zentralbl Gynakol; 1989; 111(21):1417-24. PubMed ID: 2557715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor markers in breast cancer.
    Tondini C; Hayes DF; Kufe DW
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):653-74. PubMed ID: 2691493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical value of CEA studies in patients with benign and malignant breast diseases with special reference to oncologic after care].
    Kunze M; Voss P; Büttner HH; Stranz G; Strache RR
    Zentralbl Gynakol; 1987; 109(24):1517-26. PubMed ID: 3442160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The many faces of breast cancer].
    Kammer G
    Schweiz Rundsch Med Prax; 1987 Apr; 76(18):485-91. PubMed ID: 3035681
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased levels of tumor markers in the follow-up of 400 patients with breast cancer without recurrence or metastasis: interpretation of false-positive results.
    Zervoudis S; Peitsidis P; Iatrakis G; Panourgias E; Koureas A; Navrozoglou I; Dubois JB
    J BUON; 2007; 12(4):487-92. PubMed ID: 18067207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reassessing tumor markers in local recurrences of breast cancer: a new insight.
    Pedrini JL; Pedrini M; Savaris RF; Machado L; Grudzinski M; Zettler CG
    Med Sci Monit; 2004 Dec; 10(12):BR462-7. PubMed ID: 15567977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.
    Marques AR; Teixeira E; Diamond J; Correia H; Santos S; Neto L; Ribeiro M; Miranda A; Passos-Coelho JL
    Breast Cancer Res Treat; 2009 Mar; 114(2):223-32. PubMed ID: 18409061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral synchronous breast cancer. A clinical dilemma.
    Guraya SY; Khairy GA
    Saudi Med J; 2004 Dec; 25(12):2024-5. PubMed ID: 15711694
    [No Abstract]   [Full Text] [Related]  

  • 10. [Modified breast cancer after care].
    Jäger W; Merkle E; Tulusan AH; Lang N
    Gynakol Rundsch; 1991; 31 Suppl 2():296-9. PubMed ID: 1665139
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical value of serum tumour markers TPA, TPS, TAG 12, CA 15-3 and MCA in breast cancer diagnosis; results from a prospective study.
    Eskelinen M; Hippeläinen M; Kettunen J; Salmela E; Penttilä I; Alhava E
    Anticancer Res; 1994; 14(2B):699-703. PubMed ID: 8010729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular markers in the diagnosis and staging of breast cancer.
    Dillon DA
    Semin Radiat Oncol; 2002 Oct; 12(4):305-18. PubMed ID: 12382189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [BCA225].
    Kumamoto K; Kannagi R
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():669-71. PubMed ID: 16149607
    [No Abstract]   [Full Text] [Related]  

  • 14. [MSA--a new sensitive tumor marker in breast carcinoma].
    Zahm DM; Greinke C; Nöschel H
    Zentralbl Gynakol; 1996; 118(12):659-64. PubMed ID: 9082702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic value of p53 for locoregional recurrence in mastectomy treated breast cancer patients].
    Rödel F
    Strahlenther Onkol; 2000 Dec; 176(12):586-7. PubMed ID: 11140156
    [No Abstract]   [Full Text] [Related]  

  • 16. A correlation of erythrocyte sedimentation and plasma carcinoembryonic antigen in fibrocystic disease and carcinoma of the breast.
    Thynne GS; Greening WP
    Clin Oncol; 1980 Dec; 6(4):317-21. PubMed ID: 7460405
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma carotenoids and recurrence-free survival in women with a history of breast cancer.
    Rock CL; Flatt SW; Natarajan L; Thomson CA; Bardwell WA; Newman VA; Hollenbach KA; Jones L; Caan BJ; Pierce JP
    J Clin Oncol; 2005 Sep; 23(27):6631-8. PubMed ID: 16170170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [General and specific laboratory parameters within the scope of tumor after-care in gynecologic malignancies and breast cancer].
    Kreienberg R
    Gynakologe; 1989 Feb; 22(1):55-62. PubMed ID: 2653979
    [No Abstract]   [Full Text] [Related]  

  • 19. Breast cancer: the search for new prognostic markers.
    Davis AR
    Br J Biomed Sci; 1996 Jun; 53(2):157-61. PubMed ID: 8757694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical usefulness of tumor markers in breast cancer].
    Konishi K; Karaki K; Watanabe K; Tsuda H; Konishi F
    Rinsho Byori; 1993 Oct; 41(10):1108-15. PubMed ID: 8254956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.